Clinical Significance of GPR56, Transglutaminase 2, and NF-κB in Esophageal Squamous Cell Carcinoma

REFERENCES

• International Agency for Research on Cancer. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalance Worldwide, Version 1.0, IARC Cancer Base No. 5. Lyon, France: IARC Press, 2005.
   Google Scholar
• Malkan G, Mohandas KM. Epidemiology of digestive cancers in India. I. General principles and esophageal cancer. Indian J Gastroenterol 1997;3:98–102.
   Google Scholar
• Gajalakshmi V, Swaminathan R, Shanta V. An independent survey to assess completeness of registration: population based cancer registry, Chennai, India. Asian Pac J Cancer Prev 2001;3:179–183.
   Google Scholar
• Montesano R, Hollstein M, Hainaut P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 1996;3:225–235.
   Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;2:153–156.
   Google Scholar
• Gupta NM, Jindal R, Prakash O, Gupta R, Bhasin DK. Comparison of the clinical profile and outcome for squamous cell carcinoma and adenocarcinoma of the distal esophagus and cardia in India. Surg Today 2001;5:400–404.
   Google Scholar
• Yeole BB, Kumar AV. Population-based survival from cancers having a poor prognosis in Mumbai (Bombay), India. Asian Pac J Cancer Prev 2004;2:175–182.
   Google Scholar
• Chandrashekar R, Tsuji N, Morales T, Ozols V, Mehta K. An ERp60-like protein from the filarial parasite Dirofilaria immitis has both transglutaminase and protein disulfide isomerase activity. Proc Natl Acad Sci USA 1998;95:531–536.
   PubMed Web of Science ®Google Scholar
• Mehta K. Mammalian transglutaminases: a family portrait. Prog Exp Tumor Res 2005;38:1–18.
   PubMed Web of Science ®Google Scholar
• Aeschlimann D, Thomazy V. Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect Tissue Res 2000;41:1–27.
   PubMed Web of Science ®Google Scholar
• Milakovic T, Tucholski J, McCoy E, Johnson GV. Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death. J Biol Chem 2004;279:8715–8722.
   PubMed Web of Science ®Google Scholar
• Mishra S, Murphy LJ. The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity. Biochem Biophys Res Commun 2006;339:726–730.
   PubMed Web of Science ®Google Scholar
• Mishra S, Saleh A, Espino PS, Davie JR, Murphy LJ. Phosphorylation of histones by tissue transglutaminase. J Biol Chem 2006;281:5532–5538.
   PubMed Web of Science ®Google Scholar
• Singh US, Pan J, Kao YL, Joshi S, Young KL, Baker KM. Tissue transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J Biol Chem 2003;278:391–399.
   PubMed Web of Science ®Google Scholar
• Fok JY, Ekmekcioglu S, Mehta K. Implications of tissue transglutaminase expression in malignant melanoma. Mol Cancer Ther 2006;5:1493–1503.
   PubMed Web of Science ®Google Scholar
• Mangala LS, Fok JY, Zorrilla-Calancha IR, Verma A, Mehta K. Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells. Oncogene 2007;26:2459–2470.
   PubMed Web of Science ®Google Scholar
• Verma A, Wang H, Manavathi B. Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis. Cancer Res 2006;66:10525–10533.
   PubMed Web of Science ®Google Scholar
• Hwang JY, Mangala LS, Fok JY, Lin YG, Merritt WM, Spannuth WA, Nick AM, Fiterman DJ, Vivas-Mejia PE, Deavers MT, Coleman RL, Lopez-Berestein G, Mehta K, Sood AK. Clinical and biological significance of tissue transglutaminase in ovarian carcinoma. Cancer Res 2008;68:5849–5858.
   PubMed Web of Science ®Google Scholar
• Dolcet X, Llobet D, Pallares J, Matias-Guiu X. NF-kappaB in development and progression of human cancer. Virchows Arch 2005;446:475–482.
   PubMed Web of Science ®Google Scholar
• Zandi E, Karin M. Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex. Mol Cell Biol 1999;19:4547–4551.
   PubMed Web of Science ®Google Scholar
• Ahn KS, Sethi G, Aggarwal BB. Nuclear factor-kappa B: from clone to clinic. Curr Mol Med 2007;7:619–637.
   PubMed Web of Science ®Google Scholar
• Liu M, Parker RM, Darby K, Eyre HJ, Copeland NG, Crawford J, Gilbert DJ, Sutherland GR, Jenkins NA, Herzog H. GPR56, a novel secretin-like human G-protein-coupled receptor gene. Genomics 1999;55:296–305.
   PubMed Web of Science ®Google Scholar
• Fredriksson R, Lagerstrom MC, Hoglund PJ, Schioth HB. Novel human G protein-coupled receptors with long N-terminals containing GPS domains and Ser/Thr-rich regions. FEBS Lett 2002;531:407–414.
   PubMed Web of Science ®Google Scholar
• Fredriksson R, Gloriam DE, Hoglund PJ, Lagerstrom MC, Schioth HB. There exist at least 30 human G-protein-coupled receptors with long Ser/Thr-rich N-termini. Biochem Biophys Res Commun 2003;301:725–734.
   PubMed Web of Science ®Google Scholar
• Bjarnadottir TK, Fredriksson R, Hoglund PJ, Gloriam DE, Lagerstrom MC, Schioth HB. The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. Genomics 2004;84:23–33.
   PubMed Web of Science ®Google Scholar
• Bjarnadottir TK, Fredriksson R, Schioth HB. The adhesion GPCRs: a unique family of G protein-coupled receptors with important roles in both central and peripheral tissues. Cell Mol Life Sci 2007;64:2104–2119.
   PubMed Web of Science ®Google Scholar
• Piao X, Hill RS, Bodell A, Chang BS, Basel-Vanagaite L, Straussberg R, Dobyns WB, Qasrawi B, Winter RM, Innes AM, Voit T, Ross ME, Michaud JL, Descarie JC, Barkovich AJ, Walsh CA. G protein-coupled receptor-dependent development of human frontal cortex. Science 2004;303:2033–2036.
   PubMed Web of Science ®Google Scholar
• Shashidhar S, Lorente G, Nagavarapu U, Nelson A, Kuo J, Cummins J, Nikolich K, Urfer R, Foehr ED. GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion. Oncogene 2005;24:1673–1682.
   PubMed Web of Science ®Google Scholar
• Ke N, Sundaram R, Liu G, Chionis J, Fan W, Rogers C, Awad T, Grifman M, Yu D, Wong-Staal F, Li QX. Orphan G protein-coupled receptor GPR56 plays a role in cell transformation and tumorigenesis involving the cell adhesion pathway. Mol Cancer Ther 2007;6:1840–1850.
   PubMed Web of Science ®Google Scholar
• Sud N, Sharma R, Ray R, Chattopadhyay TK, Ralhan R. Differential expression of G-protein coupled receptor 56 in human esophageal squamous cell carcinoma. Cancer Lett 2006;233:265–270.
   PubMed Web of Science ®Google Scholar
• Mehta K, Fok JY, Miller FR, Koul D, Sahin AA. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer. Clin Cancer Res 2004;10:8068–8076.
   PubMed Web of Science ®Google Scholar
• Mehta K. High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells. Int J Cancer 1994;58:400–406.
   PubMed Web of Science ®Google Scholar
• Herman JF, Mangla LS, Mehra K. Implication of tissue transglutaminase (TG2) expression in drug resistant breast cancer (MCF-7) cells. Oncogene 2006;25:3049–3058.
   PubMed Web of Science ®Google Scholar
• Kim DS, Park SS, Nam BH. Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kB inactivation. Cancer Res 2006;66:10936–10943.
   PubMed Web of Science ®Google Scholar
• Abdel-Latif MM, O’Riordan J, Windle HJ, Carton E, Ravi N, Kelleher D, Reynolds JV. NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemo radiotherapy. Ann Surg 2004;239:491–500.
   PubMed Web of Science ®Google Scholar
• Wang W, Abbruzzese AL, Evans DB, Larry L, Cleary KR, Chiao PJ. The nuclear factor-κB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 1999;5:119–127.
   PubMed Web of Science ®Google Scholar
• Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonensheinet GE. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 1997;100:2952–2960.
   PubMed Web of Science ®Google Scholar
• Bours V, Dejardin E, Goujon-Letawe F, Merville MP, Castronovo V. The NF-κB transcription factor and cancer: high expression of NF-kB- and IkB-related proteins in tumor cell lines. Biochem Pharmacol 1994;47:145–149.
   PubMed Web of Science ®Google Scholar
• Sawhney M, Rohatgi N, Kaur J, Shishodia S, Sethi G, Gupta SD, Deo SV, Shukla NK, Aggarwal BB, Ralhan R. Expression of NF-κB parallels Cox2 expression in oral precancer and cancer: association with smokeless tobacco. Int J Cancer 2007;120:2545–2556.
   PubMed Web of Science ®Google Scholar
• Lee J; Kim YS, Choi DH, Bang MS, Han TR, Joh TH, Kim SY. Transglutaminase 2 induces nuclear factor-κB activation via a novel pathway in BV-2 microglia. J Biol Chem 2004;279:53725–53735.
   PubMed Web of Science ®Google Scholar
• Mann AP, Verma A, Sethi G, Manavathi B, Wang H, Fok JY, Kunnumakkara AB, Kumar R, Aggarwal BB, Mehta K Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-κB in cancer cells: delineation of a novel pathway. Cancer Res 2006;66:8788–8795.
   PubMed Web of Science ®Google Scholar
• Kim DS, Park SS, Nam BH, Kim IH, Kim SY. Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-κB inactivation. Cancer Res 2006;66:10936–10943.
   PubMed Web of Science ®Google Scholar
• Jin Z, Tietjen I, Bu L, Liu-Yesucevitz L, Gaur SK, Walsh CA, Piao X. Disease-associated mutations affect GPR56 protein trafficking and cell surface expression. Hum Mol Genet 2007;16:1972–1985.
   PubMed Web of Science ®Google Scholar
• Xu L, Begum S, Hearn JD, Hynes RO. GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis. Proc Natl Acad Sci U S A 2006;103:9023–9028.
   PubMed Web of Science ®Google Scholar
• Iguchi T, Sakata K, Yoshizaki K, Tago K, Mizuno N, Itoh H. Orphan G protein-coupled receptor GPR56 regulates neural progenitor cell migration via a G alpha 12/13 and Rho pathway. J Biol Chem 2008;283:14469–14478.
   PubMed Web of Science ®Google Scholar